Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer. - Zhao JJ; Fong KY; Chan YH; Tey J; Dawood S; Lee SC; Finn RS; Sundar R; Lim JSJ (Cancers, 2023)